ArticleData science in science2024
Assessment of Glioblastoma Multiforme Tumor Heterogeneity via MRI-derived Shape and Intensity Features.
Article in Data science in science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Graph informed biomarker discovery framework using transcriptomic machine learning for glioblastoma prognosis.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
We use a geometric approach to jointly characterize tumor shape and intensity along the tumor contour, as captured in magnetic resonance images, in the context of glioblastoma multiforme. Key properties of the proposed shape+intensity representation include invariance to translation, scale, rotation and reparameterization, which enable objective characterization and comparison of these crucial tumor features. The representation further allows the user to tune the emphasis of the shape and intensity components during registration, comparison and statistical summarization (averaging, computation of overall variance and exploration of variability via principal component analysis). In addition, we define a composite distance that is able to integrate shape and intensity information from two imaging modalities. The proposed framework can be integrated with distance-based clustering for the purpose of discovering groups of subjects with distinct survival prognosis. When applied to a cohort of subjects with glioblastoma multiforme, we discover groups with large median survival differences. We further tie the subjects' cluster memberships to tumor heterogeneity. Our results suggest that tumor shape variation plays an important role in disease prognosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.